James R. Hitchin
- Hematology top 5%
- Acute Myeloid Leukemia Research 2
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 3
- Cancer therapeutics and mechanisms 3
- Chemical Synthesis and Analysis 2
-
- PARP inhibition in cancer therapy 2
-
- Fluorine in Organic Chemistry 2
- Co-authors
- Allan M. JordanDonald OgilvieTim C. P. SomervailleJames T. LynchYaoyong LiFilippo CiceriGary J. SpencerWilliam J. Harris
- Cited by
- HematologyMolecular BiologyOncology
- Partner nations
- United KingdomSwitzerlandAustria
In The Last Decade
James R. Hitchin
19 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hematology 191
- Molecular Biology 848
- Oncology 189
- Physiology 23
- Aging 8
Countries citing papers authored by James R. Hitchin
This map shows the geographic impact of James R. Hitchin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Hitchin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Hitchin more than expected).
Fields of papers citing papers by James R. Hitchin
This network shows the impact of papers produced by James R. Hitchin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Hitchin. The network helps show where James R. Hitchin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James R. Hitchin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2022 | 3 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 137 | |
| 5 | 2018 | 26 | |
| 6 | 2016 | 94 | |
| 7 | 2015 | 46 | |
| 8 | 2015 | 1 | |
| 9 | 2014 | 37 | |
| 10 | 2013 | 43 | |
| 11 | 2013 | 55 | |
| 12 | 2013 | 50 | |
| 13 | 2012 | 15 | |
| 14 | The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cellsbreakdown → | 2012 | 432 |
| 15 | 2012 | 5 | |
| 16 | 2012 | 53 | |
| 17 | 2011 | 3 | |
| 18 | 2011 | 5 | |
| 19 | 2008 | 2 |
About James R. Hitchin
James R. Hitchin is a scholar working on Pharmaceutical Science, Hematology and Molecular Biology, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer therapeutics and mechanisms (3 papers), Acute Myeloid Leukemia Research (2 papers), Chemical Synthesis and Analysis (2 papers), Fluorine in Organic Chemistry (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Hematology (191 citations), Molecular Biology (848 citations) and Oncology (189 citations). James R. Hitchin has collaborated with scholars based in United Kingdom, Switzerland and Austria. Frequent co-authors include Allan M. Jordan, Donald Ogilvie, Tim C. P. Somervaille, James T. Lynch, Yaoyong Li, Filippo Ciceri, Gary J. Spencer, William J. Harris, Xu Huang and Brigit Greystoke. Their work appears in journals such as Cancer Cell, Cancer Research and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.